Santhera Pharmaceuticals Holding's total assets for Q2 2025 were CHF130.77M, a decrease of -14.24% from the previous quarter. SPHDF total liabilities were CHF133.33M for the fiscal quarter, a 6.84% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.